ADC	Antibody-Drug Conjugate
AE	Adverse Event
ASCL1	Achaete-Scute Family BHLH Transcription Factor 1
BCL-2	B-cell lymphoma 2
BiTE	Bispecific T-cell Engager
B7-H3	B7 Homolog 3/CD276
cCRT	Concurrent Chemoradiotherapy
CI	Confidence Interval
CNS	Central Nervous System
CRPC	Castration-Resistant Prostate Cancer
CRS	Cytokine-Release Syndrome
CRT	Chemoradiotherapy
CT	Computed Tomography
CTFI	Chemotherapy-Free Interval
CTLA-4	Cytotoxic T-Lymphocyte Antigen 4
CTX	Chemotherapy
DLCO	Diffusing Capacity of the Lung for Carbon Monoxide
DLL3	Delta-like protein 3
DLT	Dose-Limiting Toxicity
DCR	Disease Control Rate
DOR	Duration Of Response
ED-SCLC	Extensive-Disease small cell lung cancer
EMA	National Comprehensive Cancer Network
ESMO	European Society For Medical Oncology
EZH2	Enhancer of Zeste Homolog 2
FDA	United States Food and Drug Administration
FDG-PET	Fluorodeoxyglucose Positron Emission Tomography
FEV1	Forced Expiratory Volume in 1 Second
FL	Follicular Lymphoma
HR	Hazard Ratio
ICANS	Immune Effector Cell-Associated Neurotoxicity Syndrome
IGFR1	Insulin-like Growth Factor 1 Receptor
ILD	Interstitial Lung Disease
IO	Immunotherapy
irAE	Immune-Related Adverse Events
LD-SCLC	Limited-Disease small cell lung cancer
LDH	Lactate Dehydrogenase
MRI	Magnetic Resonance Imaging
MYC	Myelocytomatosis oncogene
NCAM	Neural Cell Adhesion Molecule, also known as CD56
NCCN	National Comprehensive Cancer Network
NEC	Neuroendocrine Carcinoma
NEURO1	Neurogenic Differentiation Factor 1
NOTCH	Neurogenic locus notch homolog (NOTCH) signaling pathway gene
NSCLC	Non-Small Cell Lung Cancer
NSE	Neuron-Specific Enolase
ORR	Objective Response Rate
OS	Overall Survival
PARP	Poly ADP-ribose Polymerase
PARPi	Poly ADP-ribose Polymerase inhibitor
PCI	Prophylactic Cranial Irradiation
PD-1	Programmed Cell Death Protein 1
PD-L1	Programmed Death-Ligand 1
PFS	Progression-Free Survival
POU2F3	POU Class 2 Homeobox 3
PR	Partial Response
PROTAC	Proteolysis-Targeting Chimera
PS	Performance Status
RB1	Retinoblastoma 1
SCLC	Small cell lung cancer
SD	Stable Disease
SEZ6	Seizure-Related 6 Homolog
SG	Sacituzumab Govitecan
SIADH	Syndrome of Inappropriate Antidiuretic Hormone Secretion
SLFN11	Schlafen Family Member 11
SOC	Standarf Of Care
TEAE	Treatment-Emergent Adverse Event
TKI	Tyrosine Kinase Inhibitor
TP53	Tumor protein p53
TRAE	Treatment-Related Adverse Events
Trop-2	Tumor-associated calcium signal transducer 2
TTF-1	Thyroid Transcription Factor-1
UICC	Union for International Cancer Control
VC	Vital Capacity
VEGF	Vascular Endothelial Growth Factor
VOD	Veno-Occlusive Disease
YAP1	Yes-associated protein 1